AXGN — Axogen Inc · catalysts, narrative & risks

Overview

Axogen, Inc. (NASDAQ: AXGN) is a Machua, Florida-based medical device company focused on peripheral nerve regeneration and repair, with a product portfolio including Avance, Axoguard, and Avive+ products [4], [6], [18]. As of early October 2026 the company carries a market capitalization in the range of ~$2.0–2.2 billion [16], [20], trading around $37.39 as of October 2, 2026 [19], [20].

Recent Catalysts (last ~1–3 months)